sponsorship image

Hair loss (alopecia) is expected. In fact, research suggests that around 57% of women and 73% of men will experience some degree of hair loss throughout their lifetime.

More common than hair loss itself are the myriad of products available to treat individuals with different forms of alopecia. Do a quick Google search on “hair loss treatments,” and you’ll quickly find yourself lost in a difficult-to-navigate jungle of products ranging from minoxidil to hair growth supplements.

While some treatments are approved by regulatory agencies and backed by scientific research, most products on the market overpromise results. More often than not such companies lack adequate evidence to back up their claims, leaving consumers to fall for unrealistic expectations. 

However, there is truly no one-size-fits-all approach to hair growth, and what works best for you might have little or no effect on another—so the big question is where to begin?

Why am I losing hair? 

Before delving into the different treatment options for hair loss, it is important to understand the fundamental factors that influence hair loss. 

While hair loss is more common with age, there are numerous factors that can influence hair loss such as:

  • Genetics
  • Hormonal changes
  • Illness
  • Lifestyle

The primary culprits: genetics & hormones 

Male and female androgenetic alopecia comprises most hair loss cases and stems from a combination of age, genetics, and hormones. 

The androgen hormone DHT(dihydrotestosterone) is a byproduct of testosterone, and responsible for the development of male traits. It’s present in both men and, to a lesser extent, in women. 

DHT is also produced in the scalp and can cause the hair follicle to slowly shrink over time, a process called follicular miniaturization. Eventually, follicular miniaturization may prevent additional hairs from growing by ultimately shrinking the follicle.

Follicular miniaturization:

DHT and hair follicle 2D

A 2017 scientific review suggests that 63 different genes play a role in hair loss rather than a singular one. Although it is not entirely understood how genetics directly impact hair loss, scientists believe that certain genetic variants determine how sensitive hair follicles are to DHT and how much DHT is synthesized in the body.

While genetics and hormones play a major role in hair reduction in men, the hormonal changes from pregnancy, illness, and menopause are substantial contributors to hormonal imbalances amongst women. 

Remember, hair loss is multifactorial

While age, genetics, and hormones are the primary culprits of hair loss, they are not the sole factors. External factors such as stress, medications, underlying illnesses, and improper nutrition are also known to play a role in the onset of hair loss.


Stress is a normal response to threat; however, higher levels of a stress hormone called, cortisol, prematurely shift the hair follicles out of their active growth phase (anagen phase) and into an early resting phase (telogen phase), halting the growth of new hair strands. The process of an early shift from the growth phase to the rest phase is called telogen effluvium.

It is considered normal to shed between 50 and 100 hairs per day, but anything over 100 may indicate telogen effluvium. Stress-induced telogen effluvium can cause one to lose more than 100 hairs per day, resulting in visibly thinning hair with time.

Chronic stress can result from a demanding lifestyle, whereas acute stress can be caused by events like the loss of a loved one, illness, or surgery.

Medical conditions   

Although an illness can cause telogen effluvium, hair loss can also stem from certain medical conditions which require special forms of treatment to assist with disease management and hair regrowth.

 A handful of conditions that can induce hair loss include Hashimoto’s disease, Grave’s disease, lupus, psoriasis, or alopecia areata (an autoimmune form of hair loss).

Inadequate nutrition 

The body requires adequate nutrition to function optimally, and hair growth is no exception. A nutritional deficiency can impact both hair structure and hair growth. Research has shown that certain deficiencies can lead to weaker, more brittle hair while others can evoke certain forms of hair loss, like telogen effluvium.

The activity in the hair follicle is highly complex involving cells that require specific nutrients to execute their tasks efficiently. Additionally, it is well understood that the intake of highly processed foods with little nutritional value can influence pro-inflammatory diseases that may negatively impact the hair growth cycle. 

What are the different treatment options? 

For some, hair loss can pose a major psychological burden impacting self-esteem and self-identity. Although factors like age and genetics can’t be changed, there are options for those with all stages of hair loss. 

The two most common treatments for androgenetic alopecia are minoxidil and finasteride. 

In most countries, minoxidil is available over the counter as a 2% and 5% as a solution and foam for both men and women. However, finasteride is a medication prescribed primarily for men as it can cause hyperandrogenism in women.

Although both treatments hold major benefits they are not without side effects, particularly with higher dose minoxidil. Some users may experience unwanted excessive hair growth on the face, which may be particularly unappealing for female users.

Additionally, some are unable to withstand minoxidil due to irritation from synthetic ingredients and stabilizers such as propylene glycol. While finasteride is typically well-tolerated amongst men it does possess side effects including, sexual dysfunction and depression.   

If hair loss is causing daily concerns you should consider making an appointment with a healthcare professional to further discuss the pros and cons of:

  • Over-the-counter options (minoxidil, other OTC options) 
  • Prescription medications (finasteride, spironolactone, oral dutasteride)
  • Hair transplant surgery 
  • Laser therapy

If you want a drug-free option 

If hair loss is caught early enough there are options to help you keep the hair you have, as well as promote regrowth.

Suppose your hair loss is early-stage, and you would like to take a more preventative measure. In that case, the bio-cosmetics company, Scandinavian Biolabs, utilizes naturally-derived growth products for both men and women to limit any potential side effects.  

The company formulates innovative products with their trademarked Bio-Pilixin® formula, which is designed to rebalance the hair growth cycle as well as support the hair follicle in a minoxidil-like mechanism, without side effects.

How does Bio-Pilixin® promote hair growth? 

Hair follicle chart for Bio-Pixilion growth

  • Increases the growth phase: The anagen phase is the period of noticeable hair growth. A shortened growth phase is one major reason for hair loss. The clinically-tested active ingredient in Bio-Pilixin® can increase the number of follicles in the anagen phase by 5%, adding about 5,000 new hairs to your head.
  • Decreases the rest phase: The resting or telogen phase is the end of hair production as the follicle becomes less active and the hair is shed. Along with extending the anagen phase, the active ingredient reduces the number of hairs in the telogen phase by 16%.
  • Supports the hair follicle: The dermal papilla cells are responsible for inducing hair growth during the anagen phase of the hair growth cycle. Bio-Pilixin® is aimed at increasing the activity of these cells to promote hair regrowth along with exerting a minoxidil-like effect by promoting blood flow to the scalp, providing nutrients and oxygen to support the hair follicle. 

Scandinavian Biolabs acknowledges biology and that hair loss stems from many different factors. Whether it’s genetics, lifestyle, or stress, the primary active ingredient in Bio-Pilixin® is clinically proven to increase hair density by 17% and reduce hair loss by 57% on average in 150 days, without side effects. 

While the Bio-Pilixin® Routine assists with most early-stage cases, the company recognizes that not every individual will respond the same to their products.

After 150-days of using their 3-step Hair Growth Routine, you automatically qualify for a 150-day money-back guarantee to ensure you find the right solution to your unique situation.

If interested in learning more about the Bio-Pilixin® formula, click here

Scandinavian Biolabs Hair Growth Routine for Men


Gan, D. C., & Sinclair, R. D. (2005, December). Prevalence of male and female pattern hair loss in Maryborough. In Journal of Investigative Dermatology Symposium Proceedings (Vol. 10, No. 3, pp. 184-189). Elsevier.

Heilmann-Heimbach, S., Herold, C., Hochfeld, L. M., Hillmer, A. M., Nyholt, D. R., Hecker, J., … & Nöthen, M. M. (2017). Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness. Nature communications, 8(1), 1-8.

Hagenaars, S. P., Hill, W. D., Harris, S. E., Ritchie, S. J., Davies, G., Liewald, D. C., … & Marioni, R. E. (2017). Genetic prediction of male pattern baldness. PLoS genetics, 13(2), e1006594.

Hadshiew, I. M., Foitzik, K., Arck, P. C., & Paus, R. (2004). Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. Journal of investigative dermatology, 123(3), 455-457.

França, K., Rodrigues, T. S., Ledon, J., Savas, J., & Chacon, A. (2013). Comprehensive overview and treatment update on hair loss.

 Hughes, E. C., & Saleh, D. (2017). Telogen effluvium.

Guo, E. L., & Katta, R. (2017). Diet and hair loss: effects of nutrient deficiency and supplement use. Dermatology practical & conceptual, 7(1), 1.

 Dawber, R. P. R., & Rundegren, J. (2003). Hypertrichosis in females applying minoxidil topical solution and in normal controls. Journal of the European Academy of Dermatology and Venereology, 17(3), 271-275.

 Friedman, E. S., Friedman, P. M., Cohen, D. E., & Washenik, K. (2002). Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. Journal of the American Academy of Dermatology, 46(2), 309-312.

Driskell, R. R., Clavel, C., Rendl, M., & Watt, F. M. (2011). Hair follicle dermal papilla cells at a glance. Journal of cell science, 124(8), 1179-1182.

Vytrus Biotech unveils Capilia Longa—the hair 3D Bio-printer, 20-nov-2016

What is your reaction?

In Love
Not Sure
Amy Revene M.B.B.S.
Amy Revene M.B.B.S. graduated from the University of Sharjah. She is currently working as a General Physician at New Hope Medical Center. Amy has a passion for research and offers her expertise and opinions helping people in their quest to lead healthy, happy lives.

    Leave a reply

    Your email address will not be published. Required fields are marked *

    You may also like

    More in:Dermatology